1. Developing quality assurance tests for simultaneous Positron Emission Tomography – Magnetic Resonance imaging for radiotherapy planning. (April 2022) Authors: Wyatt, Jonathan J.; McCallum, Hazel M.; Maxwell, Ross J. Journal: Physics and imaging in radiation oncology Issue: Volume 22(2022) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metabolic effects of a high‐fat diet post‐weaning after low maternal dietary folate during pregnancy and lactation. Issue 5 (15th January 2014) Authors: McKay, Jill A.; Xie, Long; Manus, Caroline; Langie, Sabine A. S.; Maxwell, Ross J.; Ford, Dianne; Mathers, John C. Journal: Molecular nutrition & food research Issue: Volume 58:Issue 5(2014:May) Page Start: 1087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS. (22nd May 2017) Authors: Almeida, Gilberto S.; Bawn, Carlo M.; Galler, Martin; Wilson, Ian; Thomas, Huw D.; Kyle, Suzanne; Curtin, Nicola J.; Newell, David R.; Maxwell, Ross J. Journal: NMR in biomedicine Issue: Volume 30:Number 9(2017:Sep.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent. (March 2016) Authors: Haagensen, Emma J.; Thomas, Huw D.; Mudd, Clare; Tsonou, Elpida; Wiggins, Ceri M.; Maxwell, Ross J.; Moore, Jonathan D.; Newell, David R. Journal: European journal of cancer Issue: Volume 56(2016) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent. (March 2016) Authors: Haagensen, Emma J.; Thomas, Huw D.; Mudd, Clare; Tsonou, Elpida; Wiggins, Ceri M.; Maxwell, Ross J.; Moore, Jonathan D.; Newell, David R. Journal: European journal of cancer Issue: Volume 56(2016) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗